Grace Therapeutics Inc (GRCE)
3.125
+0.02
(+0.81%)
USD |
NASDAQ |
Oct 31, 16:00
3.15
+0.02
(+0.80%)
After-Hours: 20:00
Grace Therapeutics Total Liabilities (Quarterly): 10.35M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 10.35M |
| March 31, 2024 | 11.56M |
| December 31, 2023 | 11.50M |
| September 30, 2023 | 11.46M |
| June 30, 2023 | 9.023M |
| March 31, 2023 | 11.17M |
| December 31, 2022 | 20.08M |
| September 30, 2022 | 20.75M |
| June 30, 2022 | 20.53M |
| March 31, 2022 | 20.35M |
| December 31, 2021 | 3.165M |
| September 30, 2021 | 5.592M |
| June 30, 2021 | 6.996M |
| March 31, 2021 | 6.798M |
| December 31, 2020 | 4.588M |
| September 30, 2020 | 4.959M |
| June 30, 2020 | 9.106M |
| March 31, 2020 | 9.859M |
| December 31, 2019 | 34.49M |
| September 30, 2019 | 29.85M |
| June 30, 2019 | 26.64M |
| March 31, 2019 | 25.85M |
| December 31, 2018 | 21.32M |
| September 30, 2018 | 26.89M |
| June 30, 2018 | 14.73M |
| Date | Value |
|---|---|
| March 31, 2018 | 11.41M |
| December 31, 2017 | 9.695M |
| September 30, 2017 | 3.991M |
| June 30, 2017 | 2.729M |
| November 30, 2016 | 1.354M |
| August 31, 2016 | 1.177M |
| May 31, 2016 | 1.238M |
| February 29, 2016 | 0.9571M |
| November 30, 2015 | 1.418M |
| August 31, 2015 | 1.396M |
| May 31, 2015 | 2.269M |
| February 28, 2015 | 3.181M |
| November 30, 2014 | 3.162M |
| August 31, 2014 | 8.530M |
| May 31, 2014 | 7.782M |
| February 28, 2014 | 11.10M |
| November 30, 2013 | 4.687M |
| August 31, 2013 | 3.688M |
| May 31, 2013 | 2.915M |
| February 28, 2013 | 2.390M |
| November 30, 2012 | 2.073M |
| August 31, 2012 | 1.429M |
| May 31, 2012 | 1.627M |
| February 29, 2012 | 1.267M |
| November 30, 2011 | 1.145M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.165M
Minimum
Dec 2021
34.49M
Maximum
Dec 2019
12.23M
Average
10.35M
Median
Jun 2024
Total Liabilities (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 158.91M |
| Edesa Biotech Inc | 2.361M |
| Lexaria Bioscience Corp | 0.2714M |
| Xenon Pharmaceuticals Inc | 39.96M |
| ESSA Pharma Inc | 3.805M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 69.72M |
| Shareholders Equity (Quarterly) | 59.36M |